Literature DB >> 16291768

Restricted genetic diversity of Plasmodium falciparum major merozoite surface protein 1 in isolates from Colombia.

Zilka I Terrientes1, Juana Vergara, Kenton Kramer, Sócrates Herrera, Sandra P Chang.   

Abstract

The merozoite surface protein 1 (MSP-1) gene of Plasmodium falciparum encodes a major immune target under development as a malaria vaccine. In this study, we typed MSP-1 variable regions of parasites obtained from Buenaventura, Colombia. Four MSP-1 gene types were detected corresponding to prototype and recombinant K1 and MAD20 block 4 sequences. In contrast to variability within block 4, blocks 2, 6, and 16-17 corresponded exclusively to the MAD20 allelic type. Most (80%) blood samples contained multiple MSP-1 gene types. The presence of four MSP-1 variants within block 4 against a MAD20 background indicates that current P. falciparum populations in Buenaventura are derived from parasites expressing K1 and MAD20 alleles, some of which underwent two recombination events within or flanking block 4. Restricted MSP-1 diversity appears to be relatively stable in Buenaventura and suggests that selection has resulted in the dominance of the MAD20 type in most of the polymorphic blocks with the exception of block 4.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16291768     DOI: 10.4269/ajtmh.2005.73.55

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  5 in total

1.  Longevity of Genotype-Specific Immune Responses to Plasmodium falciparum Merozoite Surface Protein 1 in Kenyan Children from Regions of Different Malaria Transmission Intensity.

Authors:  Natalie M Bowman; Jonathan J Juliano; Cynthia J Snider; Oksana Kharabora; Steven R Meshnick; John Vulule; Chandy C John; Ann M Moormann
Journal:  Am J Trop Med Hyg       Date:  2016-08-01       Impact factor: 2.345

2.  Genetic diversity of Plasmodium falciparum merozoite surface protein-1 block 2 in sites of contrasting altitudes and malaria endemicities in the Mount Cameroon region.

Authors:  Samuel Wanji; Arnaud J Kengne-Ouafo; Ebanga E Joan Eyong; Helen K Kimbi; Nicholas Tendongfor; Judith L Ndamukong-Nyanga; Hugues C Nana-Djeunga; Catherine Bourguinat; David D Sofeu-Feugaing; Claude L Charvet
Journal:  Am J Trop Med Hyg       Date:  2012-05       Impact factor: 2.345

3.  Polymorphism of the merozoite surface protein-1 block 2 region in Plasmodium falciparum isolates from Mauritania.

Authors:  Mohamed Salem O Ahmedou Salem; Magatte Ndiaye; Mohamed OuldAbdallahi; Khadijetou M Lekweiry; Hervé Bogreau; Lassana Konaté; Babacar Faye; Oumar Gaye; Ousmane Faye; Ali O Mohamed Salem O Boukhary
Journal:  Malar J       Date:  2014-01-23       Impact factor: 2.979

4.  Shift in epitope dominance of IgM and IgG responses to Plasmodium falciparum MSP1 block 4.

Authors:  Sandra P Chang; Alexander K K Kayatani; Zilka I Terrientes; Socrates Herrera; Rose G F Leke; Diane W Taylor
Journal:  Malar J       Date:  2010-01-13       Impact factor: 2.979

5.  Status of allele frequency and diversity of Plasmodium falciparum msp1, msp2 and glurp before implementation of an artemisinin-based combined therapy in Northwestern Colombia.

Authors:  Amanda Maestre; Eliana Arango; Jaime Carmona-Fonseca
Journal:  Colomb Med (Cali)       Date:  2013-12-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.